nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.14	0.165	CbGbCtD
Praziquantel—CYP3A7—Progesterone—uterine cancer	0.14	0.165	CbGbCtD
Praziquantel—CYP3A5—Progesterone—uterine cancer	0.105	0.124	CbGbCtD
Praziquantel—CYP2C19—Progesterone—uterine cancer	0.0849	0.0999	CbGbCtD
Praziquantel—CYP1A2—Progesterone—uterine cancer	0.0783	0.0922	CbGbCtD
Praziquantel—CYP2D6—Progesterone—uterine cancer	0.0645	0.076	CbGbCtD
Praziquantel—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0619	0.0729	CbGbCtD
Praziquantel—CYP3A5—Etoposide—uterine cancer	0.0471	0.0555	CbGbCtD
Praziquantel—CYP3A4—Progesterone—uterine cancer	0.041	0.0483	CbGbCtD
Praziquantel—CYP1A2—Etoposide—uterine cancer	0.035	0.0413	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—uterine cancer	0.0197	0.0232	CbGbCtD
Praziquantel—CYP3A4—Etoposide—uterine cancer	0.0184	0.0216	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—uterine cancer	0.0125	0.0147	CbGbCtD
Praziquantel—Diarrhoea haemorrhagic—Epirubicin—uterine cancer	0.0037	0.0272	CcSEcCtD
Praziquantel—Diarrhoea haemorrhagic—Doxorubicin—uterine cancer	0.00343	0.0252	CcSEcCtD
Praziquantel—Bone disorder—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.024	CcSEcCtD
Praziquantel—Abdominal discomfort—Progesterone—uterine cancer	0.00196	0.0144	CcSEcCtD
Praziquantel—Drowsiness—Progesterone—uterine cancer	0.00183	0.0134	CcSEcCtD
Praziquantel—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.0131	CcSEcCtD
Praziquantel—Body temperature increased—Carboplatin—uterine cancer	0.00175	0.0129	CcSEcCtD
Praziquantel—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.0121	CcSEcCtD
Praziquantel—Cardiac disorder—Progesterone—uterine cancer	0.00152	0.0112	CcSEcCtD
Praziquantel—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.0111	CcSEcCtD
Praziquantel—Immune system disorder—Progesterone—uterine cancer	0.00148	0.0109	CcSEcCtD
Praziquantel—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.0101	CcSEcCtD
Praziquantel—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00985	CcSEcCtD
Praziquantel—Ill-defined disorder—Progesterone—uterine cancer	0.00132	0.00972	CcSEcCtD
Praziquantel—Malaise—Progesterone—uterine cancer	0.00129	0.00944	CcSEcCtD
Praziquantel—Vertigo—Progesterone—uterine cancer	0.00128	0.00941	CcSEcCtD
Praziquantel—Convulsion—Progesterone—uterine cancer	0.00124	0.00907	CcSEcCtD
Praziquantel—Myalgia—Progesterone—uterine cancer	0.00121	0.00891	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00121	0.00885	CcSEcCtD
Praziquantel—Discomfort—Progesterone—uterine cancer	0.0012	0.00881	CcSEcCtD
Praziquantel—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.0088	CcSEcCtD
Praziquantel—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00856	CcSEcCtD
Praziquantel—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00852	CcSEcCtD
Praziquantel—Nervous system disorder—Progesterone—uterine cancer	0.00114	0.00838	CcSEcCtD
Praziquantel—Skin disorder—Progesterone—uterine cancer	0.00113	0.0083	CcSEcCtD
Praziquantel—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00822	CcSEcCtD
Praziquantel—Anorexia—Progesterone—uterine cancer	0.00111	0.00815	CcSEcCtD
Praziquantel—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00808	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00802	CcSEcCtD
Praziquantel—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00798	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00106	0.00779	CcSEcCtD
Praziquantel—Bone disorder—Epirubicin—uterine cancer	0.00104	0.0076	CcSEcCtD
Praziquantel—Somnolence—Progesterone—uterine cancer	0.00103	0.0076	CcSEcCtD
Praziquantel—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00759	CcSEcCtD
Praziquantel—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00752	CcSEcCtD
Praziquantel—Decreased appetite—Progesterone—uterine cancer	0.00101	0.00743	CcSEcCtD
Praziquantel—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00738	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Progesterone—uterine cancer	0.00101	0.00738	CcSEcCtD
Praziquantel—Fatigue—Progesterone—uterine cancer	0.001	0.00737	CcSEcCtD
Praziquantel—Atrioventricular block—Epirubicin—uterine cancer	0.000965	0.00708	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000961	0.00706	CcSEcCtD
Praziquantel—Feeling abnormal—Progesterone—uterine cancer	0.000959	0.00704	CcSEcCtD
Praziquantel—Bone disorder—Doxorubicin—uterine cancer	0.000958	0.00704	CcSEcCtD
Praziquantel—Gastrointestinal pain—Progesterone—uterine cancer	0.000952	0.00699	CcSEcCtD
Praziquantel—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.00688	CcSEcCtD
Praziquantel—Ill-defined disorder—Dactinomycin—uterine cancer	0.000935	0.00687	CcSEcCtD
Praziquantel—Urticaria—Progesterone—uterine cancer	0.000925	0.00679	CcSEcCtD
Praziquantel—Abdominal pain—Progesterone—uterine cancer	0.00092	0.00676	CcSEcCtD
Praziquantel—Body temperature increased—Progesterone—uterine cancer	0.00092	0.00676	CcSEcCtD
Praziquantel—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00673	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000911	0.00669	CcSEcCtD
Praziquantel—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00668	CcSEcCtD
Praziquantel—Malaise—Dactinomycin—uterine cancer	0.000909	0.00667	CcSEcCtD
Praziquantel—Atrioventricular block—Doxorubicin—uterine cancer	0.000893	0.00655	CcSEcCtD
Praziquantel—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000869	0.00638	CcSEcCtD
Praziquantel—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000863	0.00633	CcSEcCtD
Praziquantel—Myalgia—Dactinomycin—uterine cancer	0.000858	0.0063	CcSEcCtD
Praziquantel—Hypersensitivity—Progesterone—uterine cancer	0.000858	0.0063	CcSEcCtD
Praziquantel—Discomfort—Dactinomycin—uterine cancer	0.000848	0.00623	CcSEcCtD
Praziquantel—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00615	CcSEcCtD
Praziquantel—Asthenia—Progesterone—uterine cancer	0.000835	0.00613	CcSEcCtD
Praziquantel—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00612	CcSEcCtD
Praziquantel—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00612	CcSEcCtD
Praziquantel—Pruritus—Progesterone—uterine cancer	0.000824	0.00605	CcSEcCtD
Praziquantel—Diarrhoea—Progesterone—uterine cancer	0.000797	0.00585	CcSEcCtD
Praziquantel—Anorexia—Dactinomycin—uterine cancer	0.000784	0.00576	CcSEcCtD
Praziquantel—Cardiac disorder—Etoposide—uterine cancer	0.000778	0.00571	CcSEcCtD
Praziquantel—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.00571	CcSEcCtD
Praziquantel—Dizziness—Progesterone—uterine cancer	0.00077	0.00565	CcSEcCtD
Praziquantel—Immune system disorder—Etoposide—uterine cancer	0.000757	0.00556	CcSEcCtD
Praziquantel—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000757	0.00556	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00075	0.0055	CcSEcCtD
Praziquantel—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00548	CcSEcCtD
Praziquantel—Vomiting—Progesterone—uterine cancer	0.00074	0.00543	CcSEcCtD
Praziquantel—Rash—Progesterone—uterine cancer	0.000734	0.00539	CcSEcCtD
Praziquantel—Dermatitis—Progesterone—uterine cancer	0.000733	0.00538	CcSEcCtD
Praziquantel—Headache—Progesterone—uterine cancer	0.000729	0.00535	CcSEcCtD
Praziquantel—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000722	0.0053	CcSEcCtD
Praziquantel—Decreased appetite—Dactinomycin—uterine cancer	0.000715	0.00525	CcSEcCtD
Praziquantel—Fatigue—Dactinomycin—uterine cancer	0.000709	0.00521	CcSEcCtD
Praziquantel—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00512	CcSEcCtD
Praziquantel—Nausea—Progesterone—uterine cancer	0.000691	0.00508	CcSEcCtD
Praziquantel—Feeling abnormal—Dactinomycin—uterine cancer	0.000678	0.00498	CcSEcCtD
Praziquantel—Ill-defined disorder—Etoposide—uterine cancer	0.000677	0.00497	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000673	0.00494	CcSEcCtD
Praziquantel—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000671	0.00492	CcSEcCtD
Praziquantel—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000665	0.00488	CcSEcCtD
Praziquantel—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000665	0.00488	CcSEcCtD
Praziquantel—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000661	0.00485	CcSEcCtD
Praziquantel—Malaise—Etoposide—uterine cancer	0.000658	0.00483	CcSEcCtD
Praziquantel—Vertigo—Etoposide—uterine cancer	0.000656	0.00481	CcSEcCtD
Praziquantel—Abdominal pain—Dactinomycin—uterine cancer	0.00065	0.00477	CcSEcCtD
Praziquantel—Body temperature increased—Dactinomycin—uterine cancer	0.00065	0.00477	CcSEcCtD
Praziquantel—Convulsion—Etoposide—uterine cancer	0.000632	0.00464	CcSEcCtD
Praziquantel—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000627	0.0046	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000617	0.00453	CcSEcCtD
Praziquantel—Discomfort—Etoposide—uterine cancer	0.000614	0.00451	CcSEcCtD
Praziquantel—Hypersensitivity—Dactinomycin—uterine cancer	0.000606	0.00445	CcSEcCtD
Praziquantel—Asthenia—Dactinomycin—uterine cancer	0.00059	0.00433	CcSEcCtD
Praziquantel—Eosinophilia—Epirubicin—uterine cancer	0.000581	0.00427	CcSEcCtD
Praziquantel—Skin disorder—Etoposide—uterine cancer	0.000578	0.00425	CcSEcCtD
Praziquantel—Anorexia—Etoposide—uterine cancer	0.000568	0.00417	CcSEcCtD
Praziquantel—Diarrhoea—Dactinomycin—uterine cancer	0.000563	0.00413	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—uterine cancer	0.000538	0.00395	CcSEcCtD
Praziquantel—Somnolence—Etoposide—uterine cancer	0.000529	0.00389	CcSEcCtD
Praziquantel—Drowsiness—Epirubicin—uterine cancer	0.000523	0.00384	CcSEcCtD
Praziquantel—Vomiting—Dactinomycin—uterine cancer	0.000523	0.00384	CcSEcCtD
Praziquantel—Rash—Dactinomycin—uterine cancer	0.000519	0.00381	CcSEcCtD
Praziquantel—Decreased appetite—Etoposide—uterine cancer	0.000518	0.0038	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Etoposide—uterine cancer	0.000514	0.00377	CcSEcCtD
Praziquantel—Fatigue—Etoposide—uterine cancer	0.000513	0.00377	CcSEcCtD
Praziquantel—Feeling abnormal—Etoposide—uterine cancer	0.000491	0.0036	CcSEcCtD
Praziquantel—Nausea—Dactinomycin—uterine cancer	0.000489	0.00359	CcSEcCtD
Praziquantel—Gastrointestinal pain—Etoposide—uterine cancer	0.000487	0.00357	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—uterine cancer	0.000484	0.00356	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—uterine cancer	0.000478	0.00351	CcSEcCtD
Praziquantel—Urticaria—Etoposide—uterine cancer	0.000473	0.00347	CcSEcCtD
Praziquantel—Abdominal pain—Etoposide—uterine cancer	0.000471	0.00346	CcSEcCtD
Praziquantel—Body temperature increased—Etoposide—uterine cancer	0.000471	0.00346	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—uterine cancer	0.000443	0.00325	CcSEcCtD
Praziquantel—Hypersensitivity—Etoposide—uterine cancer	0.000439	0.00322	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—uterine cancer	0.000436	0.0032	CcSEcCtD
Praziquantel—Asthenia—Etoposide—uterine cancer	0.000427	0.00314	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—uterine cancer	0.000424	0.00312	CcSEcCtD
Praziquantel—Pruritus—Etoposide—uterine cancer	0.000421	0.00309	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—uterine cancer	0.00042	0.00308	CcSEcCtD
Praziquantel—Diarrhoea—Etoposide—uterine cancer	0.000407	0.00299	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—uterine cancer	0.000403	0.00296	CcSEcCtD
Praziquantel—Dizziness—Etoposide—uterine cancer	0.000394	0.00289	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—uterine cancer	0.000393	0.00288	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—uterine cancer	0.000388	0.00285	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—uterine cancer	0.00038	0.00279	CcSEcCtD
Praziquantel—Vomiting—Etoposide—uterine cancer	0.000379	0.00278	CcSEcCtD
Praziquantel—Rash—Etoposide—uterine cancer	0.000375	0.00276	CcSEcCtD
Praziquantel—Dermatitis—Etoposide—uterine cancer	0.000375	0.00275	CcSEcCtD
Praziquantel—Headache—Etoposide—uterine cancer	0.000373	0.00274	CcSEcCtD
Praziquantel—Malaise—Epirubicin—uterine cancer	0.000369	0.00271	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—uterine cancer	0.000367	0.0027	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—uterine cancer	0.000354	0.0026	CcSEcCtD
Praziquantel—Nausea—Etoposide—uterine cancer	0.000354	0.0026	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—uterine cancer	0.000351	0.00258	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—uterine cancer	0.000348	0.00256	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000346	0.00254	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—uterine cancer	0.000344	0.00253	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—uterine cancer	0.000341	0.00251	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—uterine cancer	0.00034	0.0025	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—uterine cancer	0.000328	0.00241	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—uterine cancer	0.000327	0.0024	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—uterine cancer	0.000324	0.00238	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—uterine cancer	0.000322	0.00237	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00032	0.00235	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—uterine cancer	0.000318	0.00234	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—uterine cancer	0.000318	0.00234	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000304	0.00223	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—uterine cancer	0.000303	0.00222	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—uterine cancer	0.0003	0.0022	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—uterine cancer	0.000297	0.00218	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—uterine cancer	0.000294	0.00216	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—uterine cancer	0.00029	0.00213	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000288	0.00212	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—uterine cancer	0.000288	0.00211	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000281	0.00207	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—uterine cancer	0.000275	0.00202	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—uterine cancer	0.000275	0.00202	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—uterine cancer	0.000273	0.002	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—uterine cancer	0.000269	0.00197	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000267	0.00196	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—uterine cancer	0.000266	0.00195	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—uterine cancer	0.000265	0.00195	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—uterine cancer	0.000264	0.00194	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—uterine cancer	0.000264	0.00194	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—uterine cancer	0.000255	0.00187	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000253	0.00185	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—uterine cancer	0.000246	0.00181	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—uterine cancer	0.000245	0.0018	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—uterine cancer	0.000244	0.00179	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—uterine cancer	0.000244	0.00179	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—uterine cancer	0.00024	0.00176	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—uterine cancer	0.000236	0.00173	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—uterine cancer	0.000228	0.00168	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—uterine cancer	0.000228	0.00167	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—uterine cancer	0.000222	0.00163	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—uterine cancer	0.000221	0.00162	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—uterine cancer	0.000219	0.0016	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—uterine cancer	0.000212	0.00156	CcSEcCtD
Praziquantel—CYP3A43—Biological oxidations—CYP11A1—uterine cancer	0.000212	0.0145	CbGpPWpGaD
Praziquantel—Diarrhoea—Doxorubicin—uterine cancer	0.000211	0.00155	CcSEcCtD
Praziquantel—Rash—Epirubicin—uterine cancer	0.00021	0.00155	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—uterine cancer	0.00021	0.00154	CcSEcCtD
Praziquantel—CYP3A43—Metapathway biotransformation—CYP11A1—uterine cancer	0.000209	0.0143	CbGpPWpGaD
Praziquantel—Headache—Epirubicin—uterine cancer	0.000209	0.00154	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—uterine cancer	0.000204	0.0015	CcSEcCtD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000198	0.0136	CbGpPWpGaD
Praziquantel—Nausea—Epirubicin—uterine cancer	0.000198	0.00146	CcSEcCtD
Praziquantel—CYP3A43—Metapathway biotransformation—AKR1C3—uterine cancer	0.000198	0.0135	CbGpPWpGaD
Praziquantel—Vomiting—Doxorubicin—uterine cancer	0.000196	0.00144	CcSEcCtD
Praziquantel—CYP3A7—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000196	0.0134	CbGpPWpGaD
Praziquantel—Rash—Doxorubicin—uterine cancer	0.000195	0.00143	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—uterine cancer	0.000195	0.00143	CcSEcCtD
Praziquantel—Headache—Doxorubicin—uterine cancer	0.000194	0.00142	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—uterine cancer	0.000183	0.00135	CcSEcCtD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000161	0.011	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—CYP19A1—uterine cancer	0.000156	0.0107	CbGpPWpGaD
Praziquantel—CYP3A43—Metapathway biotransformation—CYP19A1—uterine cancer	0.000154	0.0105	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—AKR1B10—uterine cancer	0.000152	0.0104	CbGpPWpGaD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000146	0.00998	CbGpPWpGaD
Praziquantel—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000144	0.00987	CbGpPWpGaD
Praziquantel—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000144	0.00985	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000143	0.00981	CbGpPWpGaD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000142	0.00968	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—AKR1B1—uterine cancer	0.000141	0.00963	CbGpPWpGaD
Praziquantel—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000121	0.00828	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000121	0.00825	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000121	0.00825	CbGpPWpGaD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000118	0.00809	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000116	0.00795	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000111	0.00758	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	0.00011	0.00749	CbGpPWpGaD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000109	0.00748	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000106	0.00721	CbGpPWpGaD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000104	0.00712	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	0.000103	0.00707	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000102	0.00697	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	0.000102	0.00696	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000101	0.00688	CbGpPWpGaD
Praziquantel—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	9.44e-05	0.00645	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	9.08e-05	0.0062	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.99e-05	0.00615	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.64e-05	0.00591	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.56e-05	0.00585	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	8.55e-05	0.00584	CbGpPWpGaD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8.53e-05	0.00583	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	8.47e-05	0.00579	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	8.43e-05	0.00576	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—NDUFB11—uterine cancer	8.39e-05	0.00573	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—SRD5A2—uterine cancer	8.39e-05	0.00573	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.27e-05	0.00565	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.16e-05	0.00558	CbGpPWpGaD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.05e-05	0.0055	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	7.96e-05	0.00544	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	7.87e-05	0.00538	CbGpPWpGaD
Praziquantel—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	7.86e-05	0.00537	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	7.79e-05	0.00532	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.51e-05	0.00513	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	7.47e-05	0.00511	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.41e-05	0.00506	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	7.24e-05	0.00495	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	7.01e-05	0.00479	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.67e-05	0.00456	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.62e-05	0.00452	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	6.6e-05	0.00451	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.58e-05	0.0045	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	6.56e-05	0.00448	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.36e-05	0.00435	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	6.29e-05	0.0043	CbGpPWpGaD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.28e-05	0.00429	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	6.2e-05	0.00424	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	6.18e-05	0.00422	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	6.13e-05	0.00419	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	6.09e-05	0.00416	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.08e-05	0.00416	CbGpPWpGaD
Praziquantel—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	6.07e-05	0.00415	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—STAR—uterine cancer	6.07e-05	0.00414	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKR1B1—uterine cancer	6.07e-05	0.00414	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	5.78e-05	0.00395	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	5.75e-05	0.00393	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.41e-05	0.0037	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	5.32e-05	0.00363	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	5.25e-05	0.00359	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.15e-05	0.00352	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	5.09e-05	0.00348	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	5.07e-05	0.00347	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	4.91e-05	0.00335	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	4.84e-05	0.00331	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	4.78e-05	0.00326	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—POLD1—uterine cancer	4.76e-05	0.00325	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.73e-05	0.00324	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	4.71e-05	0.00322	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	4.67e-05	0.00319	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	4.55e-05	0.00311	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	4.5e-05	0.00308	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	4.48e-05	0.00306	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKR1C1—uterine cancer	4.45e-05	0.00304	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.45e-05	0.00304	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	4.39e-05	0.003	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	4.33e-05	0.00296	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.24e-05	0.0029	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	4.09e-05	0.0028	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.98e-05	0.00272	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—RRM2—uterine cancer	3.97e-05	0.00271	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	3.95e-05	0.0027	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—DCN—uterine cancer	3.85e-05	0.00263	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.72e-05	0.00254	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	3.67e-05	0.00251	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP11A1—uterine cancer	3.63e-05	0.00248	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.57e-05	0.00244	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.57e-05	0.00244	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.51e-05	0.0024	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.48e-05	0.00237	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.47e-05	0.00237	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.47e-05	0.00237	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKR1C3—uterine cancer	3.43e-05	0.00234	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—NDUFB11—uterine cancer	3.38e-05	0.00231	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—SRD5A2—uterine cancer	3.38e-05	0.00231	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.3e-05	0.00226	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.23e-05	0.00221	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.19e-05	0.00218	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.14e-05	0.00214	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.14e-05	0.00214	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.07e-05	0.00209	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.07e-05	0.00209	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.05e-05	0.00209	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.97e-05	0.00203	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.93e-05	0.002	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.87e-05	0.00196	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.83e-05	0.00194	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.74e-05	0.00187	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.7e-05	0.00185	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.68e-05	0.00183	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP19A1—uterine cancer	2.67e-05	0.00182	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—STK11—uterine cancer	2.67e-05	0.00182	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.52e-05	0.00173	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—STAR—uterine cancer	2.44e-05	0.00167	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKR1B1—uterine cancer	2.44e-05	0.00167	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SRD5A2—uterine cancer	2.44e-05	0.00167	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NDUFB11—uterine cancer	2.44e-05	0.00167	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.39e-05	0.00163	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.39e-05	0.00163	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.25e-05	0.00154	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.15e-05	0.00147	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.11e-05	0.00144	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.08e-05	0.00142	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—MTHFR—uterine cancer	2.01e-05	0.00137	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—POLD1—uterine cancer	1.92e-05	0.00131	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.89e-05	0.00129	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.89e-05	0.00129	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.83e-05	0.00125	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.79e-05	0.00123	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—STAR—uterine cancer	1.77e-05	0.00121	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.77e-05	0.00121	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.75e-05	0.0012	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.74e-05	0.00119	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.74e-05	0.00119	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.73e-05	0.00118	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—RRM2—uterine cancer	1.6e-05	0.00109	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—DCN—uterine cancer	1.55e-05	0.00106	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.47e-05	0.00101	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.47e-05	0.00101	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.46e-05	0.000999	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.43e-05	0.000977	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—POLD1—uterine cancer	1.39e-05	0.000947	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.38e-05	0.000943	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.37e-05	0.000933	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—STAR—uterine cancer	1.37e-05	0.000933	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.35e-05	0.000922	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.35e-05	0.000922	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.3e-05	0.000886	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—STAR—uterine cancer	1.26e-05	0.000858	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.26e-05	0.000858	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—RRM2—uterine cancer	1.16e-05	0.000789	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.14e-05	0.000776	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.14e-05	0.000776	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—DCN—uterine cancer	1.12e-05	0.000766	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PTEN—uterine cancer	1.12e-05	0.000763	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—STK11—uterine cancer	1.08e-05	0.000735	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.08e-05	0.000735	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—POLD1—uterine cancer	1.07e-05	0.000732	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—EP300—uterine cancer	1.06e-05	0.000727	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—STAR—uterine cancer	1.06e-05	0.000727	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.06e-05	0.000727	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.06e-05	0.000722	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.05e-05	0.000719	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKR1C1—uterine cancer	1e-05	0.000685	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKR1C3—uterine cancer	9.98e-06	0.000682	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—POLD1—uterine cancer	9.85e-06	0.000673	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKR1C1—uterine cancer	9.22e-06	0.00063	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—RRM2—uterine cancer	8.93e-06	0.00061	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—DCN—uterine cancer	8.67e-06	0.000593	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—POLD1—uterine cancer	8.35e-06	0.00057	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—RRM2—uterine cancer	8.21e-06	0.000561	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—STAR—uterine cancer	8.21e-06	0.000561	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.21e-06	0.000561	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP11A1—uterine cancer	8.17e-06	0.000558	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—MTHFR—uterine cancer	8.08e-06	0.000552	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—DCN—uterine cancer	7.97e-06	0.000545	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PIK3CA—uterine cancer	7.87e-06	0.000538	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.81e-06	0.000534	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—STK11—uterine cancer	7.77e-06	0.000531	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP19A1—uterine cancer	7.77e-06	0.000531	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.71e-06	0.000527	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.51e-06	0.000513	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.1e-06	0.000485	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—RRM2—uterine cancer	6.96e-06	0.000476	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—DCN—uterine cancer	6.76e-06	0.000462	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—POLD1—uterine cancer	6.44e-06	0.00044	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKT1—uterine cancer	6.43e-06	0.00044	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.36e-06	0.000435	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.03e-06	0.000412	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.01e-06	0.000411	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—STK11—uterine cancer	6.01e-06	0.000411	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.01e-06	0.000411	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—MTHFR—uterine cancer	5.84e-06	0.000399	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.64e-06	0.000386	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—STK11—uterine cancer	5.53e-06	0.000378	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.53e-06	0.000378	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.38e-06	0.000368	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—RRM2—uterine cancer	5.37e-06	0.000367	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—DCN—uterine cancer	5.21e-06	0.000356	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.91e-06	0.000336	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—STK11—uterine cancer	4.68e-06	0.00032	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.68e-06	0.00032	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.64e-06	0.000317	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—MTHFR—uterine cancer	4.52e-06	0.000309	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTEN—uterine cancer	4.5e-06	0.000307	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.4e-06	0.0003	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—EP300—uterine cancer	4.29e-06	0.000293	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.19e-06	0.000286	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MTHFR—uterine cancer	4.15e-06	0.000284	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.98e-06	0.000272	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—STK11—uterine cancer	3.61e-06	0.000247	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.61e-06	0.000247	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTHFR—uterine cancer	3.52e-06	0.00024	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTEN—uterine cancer	3.25e-06	0.000222	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.17e-06	0.000217	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.1e-06	0.000212	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—EP300—uterine cancer	3.1e-06	0.000212	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTHFR—uterine cancer	2.72e-06	0.000186	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKT1—uterine cancer	2.59e-06	0.000177	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTEN—uterine cancer	2.51e-06	0.000172	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—EP300—uterine cancer	2.4e-06	0.000164	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTEN—uterine cancer	2.31e-06	0.000158	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.29e-06	0.000157	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—EP300—uterine cancer	2.2e-06	0.000151	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTEN—uterine cancer	1.96e-06	0.000134	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKT1—uterine cancer	1.87e-06	0.000128	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—EP300—uterine cancer	1.87e-06	0.000128	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.77e-06	0.000121	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.63e-06	0.000111	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTEN—uterine cancer	1.51e-06	0.000103	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKT1—uterine cancer	1.45e-06	9.9e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—EP300—uterine cancer	1.44e-06	9.85e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.38e-06	9.44e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKT1—uterine cancer	1.33e-06	9.1e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKT1—uterine cancer	1.13e-06	7.71e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.07e-06	7.28e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKT1—uterine cancer	8.71e-07	5.95e-05	CbGpPWpGaD
